162 related articles for article (PubMed ID: 32785223)
1. A new approach to an old problem: Overview of the East African Community's Medicines Regulatory Harmonization initiative.
Ndomondo-Sigonda M; Mahlangu G; Agama-Anyetei M; Cooke E
PLoS Med; 2020 Aug; 17(8):e1003099. PubMed ID: 32785223
[No Abstract] [Full Text] [Related]
2. Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.
Arik M; Bamenyekanye E; Fimbo A; Kabatende J; Kijo AS; Simai B; Siyoi F; Azatyan S; Ambali A; Cooke E; Mashingia JH; Mwesigye JP; Ndomondo-Sigonda M; Sillo H; Sonoiya S; Tanui P; Ward M; Delano T
PLoS Med; 2020 Aug; 17(8):e1003129. PubMed ID: 32785229
[TBL] [Abstract][Full Text] [Related]
3. Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.
Sillo H; Ambali A; Azatyan S; Chamdimba C; Kaale E; Kabatende J; Lumpkin M; Mashingia JH; Mukanga D; Nyabenda B; Sematiko G; Sigonda M; Simai B; Siyoi F; Sonoiya S; Ward M; Ahonkhai V
PLoS Med; 2020 Aug; 17(8):e1003133. PubMed ID: 32785273
[TBL] [Abstract][Full Text] [Related]
4. Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.
Giaquinto AR; Grignolo A; Liberti L; Lim JCW; Salmonson T; Sauer F; Ukwu H
PLoS Med; 2020 Aug; 17(8):e1003092. PubMed ID: 32785224
[TBL] [Abstract][Full Text] [Related]
5. Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.
Mashingia JH; Ahonkhai V; Aineplan N; Ambali A; Angole A; Arik M; Azatyan S; Baak P; Bamenyekanye E; Bizoza A; Chamdimba C; Doerr P; Fimbo A; Gisagara A; Hamad H; Harris R; Hartman D; Kabatende J; Karangwa C; Kijo AS; Lumpkin M; Maboko S; Matle D; Muhairwe A; Mwesigye JP; Nyabenda B; Schulze A; Seiter A; Sematiko G; Sigonda M; Sillo H; Simai B; Siyoi F; Sonoiya S; Tanui P; Ward M; Yano F; Mukanga D
PLoS Med; 2020 Aug; 17(8):e1003134. PubMed ID: 32785219
[TBL] [Abstract][Full Text] [Related]
6. Council of Australian Therapeutic Advisory Groups: supporting the Quality Use of Medicines across the acute-care sector.
Denaro C; Gazarian M; Morris S
Intern Med J; 2015 Apr; 45(4):369-71. PubMed ID: 25827508
[No Abstract] [Full Text] [Related]
7. The African medicines regulatory harmonization initiative: rationale and benefits.
Ndomondo-Sigonda M; Ambali A
Clin Pharmacol Ther; 2011 Feb; 89(2):176-8. PubMed ID: 21252936
[TBL] [Abstract][Full Text] [Related]
8. Industrial perceptions of medicines regulatory harmonization in the East African Community.
Dansie LS; Odoch WD; Årdal C
PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
[TBL] [Abstract][Full Text] [Related]
9. Substandard and falsified antimicrobials in selected east African countries: A systematic review.
Tegegne AA; Feissa AB; Godena GH; Tefera Y; Hassen HK; Ozalp Y; Suleman S
PLoS One; 2024; 19(1):e0295956. PubMed ID: 38277385
[TBL] [Abstract][Full Text] [Related]
10. Child neurology practice and neurological disorders in East Africa.
Idro R; Newton C; Kiguli S; Kakooza-Mwesige A
J Child Neurol; 2010 Apr; 25(4):518-24. PubMed ID: 20139410
[TBL] [Abstract][Full Text] [Related]
11. [Public health and community health problems in a developed socialist society].
Serenko AF
Sov Zdravookhr; 1981; (8):3-8. PubMed ID: 7292087
[No Abstract] [Full Text] [Related]
12. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?
Walker EJ; Peterson GM; Grech J; Paragalli E; Thomas J
BMC Public Health; 2018 May; 18(1):630. PubMed ID: 29764407
[TBL] [Abstract][Full Text] [Related]
13. Future of the European Union regulatory network in the context of the uptake of new medicines.
Hoebert JM; Irs A; Mantel-Teeuwisse AK; Leufkens HG
Br J Clin Pharmacol; 2013 Jul; 76(1):1-6. PubMed ID: 23043328
[No Abstract] [Full Text] [Related]
14. What community-based education can teach tomorrow's doctors.
Whitcomb ME
Acad Med; 2005 Apr; 80(4):315-6. PubMed ID: 15793011
[No Abstract] [Full Text] [Related]
15. Monitoring the quality of medicines: results from Africa, Asia, and South America.
Hajjou M; Krech L; Lane-Barlow C; Roth L; Pribluda VS; Phanouvong S; El-Hadri L; Evans L; Raymond C; Yuan E; Siv L; Vuong TA; Boateng KP; Okafor R; Chibwe KM; Lukulay PH
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):68-74. PubMed ID: 25897073
[TBL] [Abstract][Full Text] [Related]
16. Innovative medicines: new regulatory procedures for the third millennium.
Rasi G; Bonini S
Expert Opin Biol Ther; 2015; 15 Suppl 1():S5-8. PubMed ID: 25777774
[TBL] [Abstract][Full Text] [Related]
17. Substandard and counterfeit medicines.
Rassool GH
J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
[No Abstract] [Full Text] [Related]
18. [Regulatory control of new medicines: help or hindrance?].
Vozeh S
Praxis (Bern 1994); 1999 Apr; 88(16):701-8. PubMed ID: 10355335
[TBL] [Abstract][Full Text] [Related]
19. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
[TBL] [Abstract][Full Text] [Related]
20. Requirements for generic anti-epileptic medicines: a regulatory perspective.
Maliepaard M; Hekster YA; Kappelle A; van Puijenbroek EP; Elferink AJ; Welink J; Gispen-de Wied CC; Lekkerkerker FJ
J Neurol; 2009 Dec; 256(12):1966-71. PubMed ID: 19603244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
